The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Gabapentin Drug-Global Market Insights and Sales Trends 2025

Gabapentin Drug-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1808756

No of Pages : 123

Ask Your Query
Synopsis
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The global Gabapentin Drug market size is expected to reach US$ 1985.5 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Gabapentin Drug in various end use industries. The expanding demands from the Postherpetic Neuralgia in Adults, Partial Onset Seizures and Others,, are propelling Gabapentin Drug market. Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gabapentin Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gabapentin Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gabapentin Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gabapentin Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gabapentin Drug covered in this report include Pfizer, Depomed, Apotex, Teva, Acella Pharmaceuticals, Taro, Sun Pharmaceutical, Glenmark and Amneal Pharmaceuticals, etc.
The global Gabapentin Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited
Global Gabapentin Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gabapentin Drug market, Segment by Type:
Capsule
Tablet
Oral Solution
Global Gabapentin Drug market, by Application
Postherpetic Neuralgia in Adults
Partial Onset Seizures
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Gabapentin Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Gabapentin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Gabapentin Drug Market Overview
1.1 Gabapentin Drug Product Overview
1.2 Gabapentin Drug Market Segment by Type
1.2.1 Capsule
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Global Gabapentin Drug Market Size by Type
1.3.1 Global Gabapentin Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Gabapentin Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Gabapentin Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gabapentin Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Gabapentin Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Gabapentin Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Gabapentin Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Gabapentin Drug Sales Breakdown by Type (2018-2023)
2 Global Gabapentin Drug Market Competition by Company
2.1 Global Top Players by Gabapentin Drug Sales (2018-2023)
2.2 Global Top Players by Gabapentin Drug Revenue (2018-2023)
2.3 Global Top Players by Gabapentin Drug Price (2018-2023)
2.4 Global Top Manufacturers Gabapentin Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gabapentin Drug Market Competitive Situation and Trends
2.5.1 Gabapentin Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Gabapentin Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Gabapentin Drug Market
2.8 Key Manufacturers Gabapentin Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gabapentin Drug Status and Outlook by Region
3.1 Global Gabapentin Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Gabapentin Drug Historic Market Size by Region
3.2.1 Global Gabapentin Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Gabapentin Drug Sales in Value by Region (2018-2023)
3.2.3 Global Gabapentin Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Gabapentin Drug Forecasted Market Size by Region
3.3.1 Global Gabapentin Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Gabapentin Drug Sales in Value by Region (2024-2029)
3.3.3 Global Gabapentin Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Gabapentin Drug by Application
4.1 Gabapentin Drug Market Segment by Application
4.1.1 Postherpetic Neuralgia in Adults
4.1.2 Partial Onset Seizures
4.1.3 Others
4.2 Global Gabapentin Drug Market Size by Application
4.2.1 Global Gabapentin Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Gabapentin Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Gabapentin Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gabapentin Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Gabapentin Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Gabapentin Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Gabapentin Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Gabapentin Drug Sales Breakdown by Application (2018-2023)
5 North America Gabapentin Drug by Country
5.1 North America Gabapentin Drug Historic Market Size by Country
5.1.1 North America Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Gabapentin Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Gabapentin Drug Sales in Value by Country (2018-2023)
5.2 North America Gabapentin Drug Forecasted Market Size by Country
5.2.1 North America Gabapentin Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Gabapentin Drug Sales in Value by Country (2024-2029)
6 Europe Gabapentin Drug by Country
6.1 Europe Gabapentin Drug Historic Market Size by Country
6.1.1 Europe Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Gabapentin Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Gabapentin Drug Sales in Value by Country (2018-2023)
6.2 Europe Gabapentin Drug Forecasted Market Size by Country
6.2.1 Europe Gabapentin Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Gabapentin Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Gabapentin Drug by Region
7.1 Asia-Pacific Gabapentin Drug Historic Market Size by Region
7.1.1 Asia-Pacific Gabapentin Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Gabapentin Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Gabapentin Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Gabapentin Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Gabapentin Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Gabapentin Drug Sales in Value by Region (2024-2029)
8 Latin America Gabapentin Drug by Country
8.1 Latin America Gabapentin Drug Historic Market Size by Country
8.1.1 Latin America Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Gabapentin Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Gabapentin Drug Sales in Value by Country (2018-2023)
8.2 Latin America Gabapentin Drug Forecasted Market Size by Country
8.2.1 Latin America Gabapentin Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Gabapentin Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Gabapentin Drug by Country
9.1 Middle East and Africa Gabapentin Drug Historic Market Size by Country
9.1.1 Middle East and Africa Gabapentin Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Gabapentin Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Gabapentin Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Gabapentin Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Gabapentin Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Gabapentin Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Gabapentin Drug Products Offered
10.1.5 Pfizer Recent Development
10.2 Depomed
10.2.1 Depomed Company Information
10.2.2 Depomed Introduction and Business Overview
10.2.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Depomed Gabapentin Drug Products Offered
10.2.5 Depomed Recent Development
10.3 Apotex
10.3.1 Apotex Company Information
10.3.2 Apotex Introduction and Business Overview
10.3.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Apotex Gabapentin Drug Products Offered
10.3.5 Apotex Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Gabapentin Drug Products Offered
10.4.5 Teva Recent Development
10.5 Acella Pharmaceuticals
10.5.1 Acella Pharmaceuticals Company Information
10.5.2 Acella Pharmaceuticals Introduction and Business Overview
10.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Acella Pharmaceuticals Gabapentin Drug Products Offered
10.5.5 Acella Pharmaceuticals Recent Development
10.6 Taro
10.6.1 Taro Company Information
10.6.2 Taro Introduction and Business Overview
10.6.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Taro Gabapentin Drug Products Offered
10.6.5 Taro Recent Development
10.7 Sun Pharmaceutical
10.7.1 Sun Pharmaceutical Company Information
10.7.2 Sun Pharmaceutical Introduction and Business Overview
10.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sun Pharmaceutical Gabapentin Drug Products Offered
10.7.5 Sun Pharmaceutical Recent Development
10.8 Glenmark
10.8.1 Glenmark Company Information
10.8.2 Glenmark Introduction and Business Overview
10.8.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Glenmark Gabapentin Drug Products Offered
10.8.5 Glenmark Recent Development
10.9 Amneal Pharmaceuticals
10.9.1 Amneal Pharmaceuticals Company Information
10.9.2 Amneal Pharmaceuticals Introduction and Business Overview
10.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Amneal Pharmaceuticals Gabapentin Drug Products Offered
10.9.5 Amneal Pharmaceuticals Recent Development
10.10 Aurobindo Pharma
10.10.1 Aurobindo Pharma Company Information
10.10.2 Aurobindo Pharma Introduction and Business Overview
10.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Aurobindo Pharma Gabapentin Drug Products Offered
10.10.5 Aurobindo Pharma Recent Development
10.11 Zydus Pharmaceuticals
10.11.1 Zydus Pharmaceuticals Company Information
10.11.2 Zydus Pharmaceuticals Introduction and Business Overview
10.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Zydus Pharmaceuticals Gabapentin Drug Products Offered
10.11.5 Zydus Pharmaceuticals Recent Development
10.12 Hi-Tech Pharmaceuticals
10.12.1 Hi-Tech Pharmaceuticals Company Information
10.12.2 Hi-Tech Pharmaceuticals Introduction and Business Overview
10.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Products Offered
10.12.5 Hi-Tech Pharmaceuticals Recent Development
10.13 Marksans Pharma
10.13.1 Marksans Pharma Company Information
10.13.2 Marksans Pharma Introduction and Business Overview
10.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Marksans Pharma Gabapentin Drug Products Offered
10.13.5 Marksans Pharma Recent Development
10.14 Mylan
10.14.1 Mylan Company Information
10.14.2 Mylan Introduction and Business Overview
10.14.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Mylan Gabapentin Drug Products Offered
10.14.5 Mylan Recent Development
10.15 InvaGen Pharmaceuticals
10.15.1 InvaGen Pharmaceuticals Company Information
10.15.2 InvaGen Pharmaceuticals Introduction and Business Overview
10.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 InvaGen Pharmaceuticals Gabapentin Drug Products Offered
10.15.5 InvaGen Pharmaceuticals Recent Development
10.16 Alkem Laboratories
10.16.1 Alkem Laboratories Company Information
10.16.2 Alkem Laboratories Introduction and Business Overview
10.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Alkem Laboratories Gabapentin Drug Products Offered
10.16.5 Alkem Laboratories Recent Development
10.17 Tris Pharma
10.17.1 Tris Pharma Company Information
10.17.2 Tris Pharma Introduction and Business Overview
10.17.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Tris Pharma Gabapentin Drug Products Offered
10.17.5 Tris Pharma Recent Development
10.18 ACI HealthCare Limited
10.18.1 ACI HealthCare Limited Company Information
10.18.2 ACI HealthCare Limited Introduction and Business Overview
10.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.18.4 ACI HealthCare Limited Gabapentin Drug Products Offered
10.18.5 ACI HealthCare Limited Recent Development
10.19 Jiangsu Hengrui Medicine
10.19.1 Jiangsu Hengrui Medicine Company Information
10.19.2 Jiangsu Hengrui Medicine Introduction and Business Overview
10.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Products Offered
10.19.5 Jiangsu Hengrui Medicine Recent Development
10.20 CSPC Ouyi Pharmaceutical
10.20.1 CSPC Ouyi Pharmaceutical Company Information
10.20.2 CSPC Ouyi Pharmaceutical Introduction and Business Overview
10.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Products Offered
10.20.5 CSPC Ouyi Pharmaceutical Recent Development
10.21 Sciegen Pharmaceuticals
10.21.1 Sciegen Pharmaceuticals Company Information
10.21.2 Sciegen Pharmaceuticals Introduction and Business Overview
10.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Sciegen Pharmaceuticals Gabapentin Drug Products Offered
10.21.5 Sciegen Pharmaceuticals Recent Development
10.22 Epic Pharma
10.22.1 Epic Pharma Company Information
10.22.2 Epic Pharma Introduction and Business Overview
10.22.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Epic Pharma Gabapentin Drug Products Offered
10.22.5 Epic Pharma Recent Development
10.23 Lupin Limited
10.23.1 Lupin Limited Company Information
10.23.2 Lupin Limited Introduction and Business Overview
10.23.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Lupin Limited Gabapentin Drug Products Offered
10.23.5 Lupin Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gabapentin Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gabapentin Drug Industrial Chain Analysis
11.4 Gabapentin Drug Market Dynamics
11.4.1 Gabapentin Drug Industry Trends
11.4.2 Gabapentin Drug Market Drivers
11.4.3 Gabapentin Drug Market Challenges
11.4.4 Gabapentin Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gabapentin Drug Distributors
12.3 Gabapentin Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock